Stock DNA
Pharmaceuticals & Biotechnology
CNY 5,251 Million (Small Cap)
13.00
NA
5.13%
-0.31
10.72%
1.86
Revenue and Profits:
Net Sales:
573 Million
(Quarterly Results - Jun 2026)
Net Profit:
72 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-2.15%
0%
-2.15%
6 Months
2.4%
0%
2.4%
1 Year
-8.95%
0%
-8.95%
2 Years
18.2%
0%
18.2%
3 Years
-0.15%
0%
-0.15%
4 Years
11.8%
0%
11.8%
5 Years
20.49%
0%
20.49%
Yabao Pharmaceutical Group Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-4.36%
EBIT Growth (5y)
15.49%
EBIT to Interest (avg)
83.75
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.19
Sales to Capital Employed (avg)
0.84
Tax Ratio
22.93%
Dividend Payout Ratio
76.09%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
9.38%
ROE (avg)
5.84%
Valuation key factors
Factor
Value
P/E Ratio
13
Industry P/E
Price to Book Value
1.38
EV to EBIT
11.93
EV to EBITDA
8.59
EV to Capital Employed
1.54
EV to Sales
1.42
PEG Ratio
0.39
Dividend Yield
6.83%
ROCE (Latest)
12.91%
ROE (Latest)
10.44%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
Jun'26
Mar'26
Change(%)
Net Sales
572.90
572.00
0.16%
Operating Profit (PBDIT) excl Other Income
128.30
157.30
-18.44%
Interest
0.20
0.20
Exceptional Items
-2.20
-14.10
84.40%
Consolidate Net Profit
72.30
107.00
-32.43%
Operating Profit Margin (Excl OI)
171.00%
222.00%
-5.10%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2026 is 0.16% vs 7.64% in Mar 2026
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2026 is -32.43% vs 5.52% in Mar 2026
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
2,223.30
2,668.50
-16.68%
Operating Profit (PBDIT) excl Other Income
453.10
424.30
6.79%
Interest
1.80
5.70
-68.42%
Exceptional Items
-38.50
-25.90
-48.65%
Consolidate Net Profit
299.90
223.90
33.94%
Operating Profit Margin (Excl OI)
143.10%
106.10%
3.70%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -16.68% vs -7.67% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 33.94% vs 24.46% in Dec 2024
About Yabao Pharmaceutical Group Co., Ltd. 
Yabao Pharmaceutical Group Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






